Shu, M. and Xiang, C. 2026. Forsythoside A attenuates metabolic dysfunction in type 2 diabetic mice by inhibiting the MAPK and activating the Nrf2 signalling pathways. Archives of Industrial Hygiene and Toxicology. 77, 1 (Mar. 2026). DOI:https://doi.org/10.2478/aiht-2026-77-4026.